| CASE REPORT |
|
| Year : 2016 | Volume
: 5
| Issue : 4 | Page : 294-296 |
|
|
Moxifloxacin-induced acute psychosis: A case report with literature review
Faizan Mazhar1, Shahzad Akram1, Nafis Haider2
1 Department of Clinical Pharmacy, Dow University Hospital, Dow University of Health Sciences, Karachi, Pakistan
2 Prince Sultan Military College of Health Sciences, King Fahad Military Medical Complex, Dhahran, Saudi Arabia
Correspondence Address:
Faizan Mazhar
Department of Clinical Pharmacy, Dow University Hospital, Dow University of Health Sciences, Karachi
Pakistan
 Source of Support: None, Conflict of Interest: None  | Check |
DOI: 10.4103/2279-042X.192457
|
|
|
Third generation quinolones are extensively used to treat a variety of common bacterial infections. Due to their extensive use in clinical practice, an increase in neuropsychiatric events has been reported. We report the case of psychotic symptoms occurs after three doses of moxifloxacin in a healthy adult male with no underlying risk factors. After the discontinuation of moxifloxacin treatment, there was a complete resolution of patient's symptoms. The case draws attention to a rare side effect of a commonly use drug and alert the clinicians to be cautious in those patients that have a baseline risk factors which makes the patient more susceptible to such adverse drug effect. |
|
|
|
| [FULL TEXT] [PDF]* |
|
 |
|
